THE PURPOSE OF THE BOSET PROJECT IS TO IMPLEMENT AND DEVELOP SERVICES AND PRODUCTS THAT AIM AT ACHIEVING A SUPPLY CHAIN OF BLOOD AND BLOOD COMPONENTS THAT IS BOTH EFFICIENT AND SAFE, AND OPTIMISED IN ORGANISATIONAL AND PRODUCTION TERMS. THROUGH THE DEVELOPMENT OF NEW TECHNOLOGIES AND INTEROPERABLE AND INTERCONNECTED DEPLOYMENT MODELS, NEW TECHNOLOGIES AND INTEROPERABLE AND INTERCONNECTED APPLICATION MODELS AIM AT PROVIDING A RESPONSE TO NEW REGULATORY NEEDS TO ENSURE SAFETY AND PERFORMANCE OF THE BLOOD AND/OR BLOOD COMPONENTS. TRANSFUSION MEDICINE TAKES PLACE IN A CONTEXT CHARACTERISED BY THE NEED, ON THE ONE HAND, TO ENSURE EFFECTIVENESS AND EFFICIENCY IN THE ASSIGNMENT OF THE SERVICE AND IN THE USE OF RESOURCES OF PUBLIC ORIGIN; TO BE ABLE TO BRING THE ACTIVITIES IN LINE WITH THE NATIONAL RULES (TRANSPOSING EUROPEAN DIRECTIVES). THE ONOMENENEATS, TRACABILITS, UNIFORMITTS AND STANDARDISATION ARE THE KEY POINTS TO WHICH THE ACTIVITIES OF TRANSFUSION MEDICINE MUST TEND TOWARDS THE END OF D